ALIVUS LIFE SCIENCES Q2 FY27 (STANDALONE) ; NET PROFIT UP 51% AT ₹197 CR (YOY), UP 23% (QOQ)

REVENUE UP 16% AT ₹682 CR (YOY), UP 6% (QOQ) EBITDA UP 48% AT ₹265 CR (YOY), UP 25% (QOQ) MARGINS AT 38.9% VS 30.5% (YOY), 33.1% (QOQ)

ALIVUS LIFE SCIENCES LTD